WOBURN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the commercialization and development of ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug ...

New York - Personal Injury - - New York Supreme Court, Erie County - Index not Assigned - In the Matter of the Application by the New York Central Mutual Fire Insurance Company (nycm) to Temporarily ...

Comprehensive overview of the evolution of transition metal-based catalysts in microbial electrolysis cells from their inception to the present. Critical design parameters of catalysts evaluated from ...

A team of researchers led by the UK’s University of Cambridge has developed an adhesive-free method of bonding ultra-thin gallium arsenide (GaAs) solar cells to borosilicate glass. The technique, ...

Have you ever stared at a colorful Excel spreadsheet, wondering how to quickly calculate totals or counts based on cell colors? It’s a common frustration for anyone managing large datasets. While ...

Abstract: This paper introduces an enhanced normalized min-sum decoder designed to address the performance and complexity challenges associated with developing parallelizable decoders for short BCH ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

The first appeal opposing a small cell wireless facility in San Mateo was granted since the city passed an ordinance tightening rules around their construction four months ago. Small cell facilities, ...

LONDON, Ontario and BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s ...